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doi:10.1016/j.asjsur.2011.08.004Summary Primary colorectal lymphoma is a rare disease that accounts for 0.16% of colorectal
malignancies. Treatments include surgical intervention with or without chemotherapy. Outcome
of this intervention among the Chinese population are lacking. Perforation resulting from chemo-
therapy may need further exploration. A retrospective review of patient records was performed
among those who were diagnosed with colorectal malignancy in a single center from January
1998 to June 2009. Ten patients met Dawson’s diagnostic criteria for primary colorectal
lymphoma [0.66% (10/1516) of all colorectal malignancies]. The male-to-female ratio was 9:1,
and median age at diagnosis was 76 years. The most common site was the cecum (nZ 5). B-cell
lymphoma was present in eight patients. Seven patients underwent surgical intervention. The
median follow-up of all patients was 16.5 months. Median survival was 17 months and 13 months
in the surgical and chemotherapy group, respectively. Primary colonic lymphoma is a rare
disease. Surgical intervention appeared to be superior to chemotherapy alone, but the findings
were limited by the small number of patients in this study. Whether surgery or chemotherapy
should be offered first remains unknown and requires further research.
Copyright ª 2011, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.Colorectal Surgery, Depart-
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n Surgical Association. Published1. Introduction
Primary colorectal lymphoma is a rare disease that
accounts for only 5.8% of gastrointestinal lymphoma and
0.16% of colorectal malignancy.1 The gastrointestinal tract
is the most common site of extranodal lymphoma, which
affects 6e12% of all patients.2,3 However, most patientsby Elsevier Taiwan LLC. All rights reserved.
Table 1 Comparison of the demographic data between
the operative and chemotherapy group.
Operative
(nZ 7)
Chemotherapy
(nZ 3)
p-value
Age (median) 78 74 0.454
Male 85.7% (6) 100% (3) 0.399
Site
Caecum 71.4% (5) 0 0.073
Sigmoid 0 33.3% (1)
Rectum 28.6% (2) 66.6% (2)
Presentation
Abdominal pain 71.4% (5) 100% (3) 0.644
Change of bowel habit 14.3% (1) 0
per Rectal bleeding 14.3% (1) 0
Abdominal mass 0 0
Intestinal obstruction 0 0
Cell type
T-cell 0 0 0.240
B-cell 85.7% (6) 66.7% (2)
Burkitt-like 0 33.3% (1)
Mantle 14.3% (1) 0
Class
I 14.3% (1) 33.3% (1) 0.728
II 57.1% (4) 33.3% (1)
III 28.6% (2) 33.3% (1)
Median survival
time (months)
17 13 0.124
112 W.-H. She et al.present late and have nonspecific symptoms such as
abdominal pain and weight loss.1,4
The number of articles concerning primary colorectal
lymphoma in the Chinese population is few. One study from
Taiwanshowedthat theproportionofT-cell lymphomas (42%),
known to have a poorer prognosis than B-cell lymphomas, is
much higher in this population than in Western populations.5
We review the incidence of primary colorectal lymphoma in
our hospital and compare it with that of other studies.
2. Patients and methods
A retrospective study was performed of all patients who pre-
sented with primary colorectal lymphoma from January 1998
to December 2008. Clinical details derived from patients’
medical records, including patient characteristics and clinical
data, type of treatment, pathologic findings, recurrence rate,
mortality, and morbidity, were recorded and analyzed.
All of the patients were diagnosed with primary colo-
rectal lymphoma preoperatively. Tissue diagnosis was ob-
tained by colonoscopy, and all patients underwent
a computed tomography (CT) scan to determine the stage
of disease and exclude metastases. Patients who had
undergone emergency surgery were also excluded.
Our patients fit Dawson’s criteria6 for the diagnosis of
primary colorectal lymphoma: histopathologic confirmation
of a lymphoproliferative neoplasm confined to the colon
and/or rectum with: (1) absence of palpable lymphadenop-
athy; (2) absence of mediastinal node enlargement; (3)
normal white cell count and differential in the evaluation of
peripheral blood; (4) a lesion confined mainly to the bowel
with only local lymphadenopathy seen at laparotomy; and
(5) absence of liver or spleen involvement at laparotomy.
Statistical Package for Social Sciences (SPSS) version 15 (SPSS
Inc., Chicago, IL, USA) was used for data analysis. Chi-square
or Fisher’s exact test was used in comparing the categorical
variables. The ManneWhitney U-test was used in comparing
the continuous variables in median values.
3. Results
During the captioned period, 1516 cases of colorectal malig-
nancy were identified from our database, and 15 patients
were found to have lymphoma involving the colorectal region.
However, only 10 patients (0.66%) fit Dawson’s criteria. Nine
patients were male and one was female. The median age at
diagnosis was 76 years (range, 69e92). Seven patients com-
plained of nonspecific abdominal pain, two patients had
a change of bowel habit, and one patient complained of
anemia. All patients underwent colonoscopy and had a biopsy
taken for tissue diagnosis. The most common site was the
cecum (50%, nZ 5), followed by the rectum (40%, nZ 4) and
sigmoid colon (10%, n Z 1). B-cell lymphoma was most
common (nZ 8), followed by Burkitt-like (nZ 1) and Mantle
cell (nZ 1). A CTscan of the thorax, abdomen, and pelvis was
performed, and none showed signs of distant metastasis.
All of the patients were assessed by physicians preop-
eratively to confirm the diagnosis and offered surgical
intervention if appropriate. Three patients (30%; disease in
cecum, sigmoid, and rectum, respectively) refused surgery
and received chemotherapy as the sole treatment. Thechoice of chemotherapeutic agent depended on tumor
pathology. There were no complications of bowel perfora-
tion during or after chemotherapy.
The remaining seven patients (70%) received surgical
intervention. A right hemicolectomy was performed for five
patients who suffered from lymphoma in the cecum. Poly-
pectomy was performed on one patient who presented with
a rectal polyp. One patient who had an abdominal perineal
resection performed died of a cardiac event soon after
surgery.
The median follow-up of all patients was 16.5 months.
Differences in demographic data of the surgical and
nonsurgical groups did not statistically affect outcomes
significantly (Table 1). The median survival times were 17
and 13 months in the surgical and nonsurgical groups,
respectively.
4. Discussion
Primary colorectal lymphomas usually present between the
fourth and seventh decades of life; the average age at
diagnosis is approximately 50 years. However, all of our
patients were elderly, with a median age of 76 years,
significantly older than patients in studies from Western
countries who had a median age of 51e55 years. Although
the exact incidence and prevalence are not known, the
incidence of colonic lymphoma among all colorectal
malignancies in our studied population (0.66%) is slightly
higher than that in the Caucasian population (0.5%).1,4,7e12
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population differs from that of other populations because
studies have shown varying results.13,14
Like results found in others’ reports, our results show
that the most common site of primary lymphoma is the
cecum, attributable to the presence of relatively abundant
lymphoid tissue.4,12,14 However, our findings that 80% of our
patients suffered from B-cell lymphoma differ from those
of Wang et al5 whose Chinese patients had predominantly
T-cell lymphoma (42%). It has been shown that the T-cell
type is associated with a poorer prognosis than B-cell
type.15,16 We cannot explain the difference.
The rarity of the disease renders clinical trials very
difficult, and the optimal treatment remains uncertain.
Most authors would offer the same treatment as used for
colorectal carcinoma: surgery with or without chemo-
therapy. However, a review of the literature indicates no
superiority of the treatment. Surgical intervention plays an
important role in the management of the disease. Surgery
with a curative intent can be offered to patients with
localized disease; palliative surgical procedures can help in
relieving obstruction or other symptoms. However, it is also
important to treat patients who present with perforation,
bleeding, or fistula. In our series, we did not randomize our
patients to either a surgical or chemotherapy arm, and we
offered surgical intervention as the initial treatment to all
the patients who were fit and operable. The three patients
who refused surgical intervention were referred for
chemotherapy. We did not observe any difference in
survival during a similar follow-up period. However, we
cannot draw any conclusions based on the small sample size
of this retrospective study. A Korean multicenter trial
showed that the outcome of patients receiving chemo-
therapy alone was poorer than that of patients who
received surgery with or without chemotherapy.13
However, this result might be explained by the fact that
most of the patients receiving chemotherapy were
suffering from T-cell lymphoma, which has been shown to
be associated with a poorer prognosis.10,13 In one of our
patients, we performed a laparoscopic abdominal perineal
resection for his rectal lymphoma, but he died soon after
surgery from a cardiovascular event. Therefore, whether
the surgery offered benefit or imposed further risk to the
patient remains unknown. Thus, the best treatment
modality for primary colonic lymphoma cannot be
concluded at this time.
One of the reported complications of chemotherapy in
treating gastrointestinal lymphoma is tumor necrosis with
bowel perforation.17,18 The tumor with possible transmural
involvement, which invades or weakens the bowel wall,
might undergo tumor necrosis, causing bowel perforation as
a result of the chemotherapy.19 There is still no consensus
or evidence to conclude the optimal timing for the
combined treatment of surgical intervention and chemo-
therapy. One recent study reported two patients with
colonic lymphoma who presented with a large bowel
perforation due to obstruction rather than necrotizing
enteropathy resulting from the chemotherapy. The series
by Kim et al13 of 95 patients with colorectal lymphoma
demonstrated that none of the patients (n Z 23; 24.5%)
who received chemotherapy alone developed bowel
perforation during chemotherapy. A literature search showsthat bowel perforation following chemotherapy alone is
uncommon; therefore, there is no solid evidence to corre-
late chemotherapy with bowel perforation.
For primary colorectal lymphoma, the evidence of
surgery as the primary treatment is not strong. Chemo-
therapy should be considered as the primary treatment if
the surgical risk is high, if it is the patient’s preference, and
if the patient understands the remote risk of bowel perfo-
ration. A preoperative CT scan can help to identify tumors
with features of full-thickness bowel involvement and
invasion. We also suggest a further exploration of the tumor
pathology (type, size of the tumor, and site of perforation)
and level of involvement of the bowel to analyze
the relationship between chemotherapy and bowel
perforation.
Our study has several limitations. This is a retrospective
study with a limited number of patients, and, as a result,
there was selection bias. The rarity of the disease rendered
a prospective study very difficult. A meta-analysis would
have helped in this case.
5. Conclusions
Primary colonic lymphoma is a rare disease. Our series
seem to show superiority of the surgical intervention;
however, it is limited by the number of patients. Whether
surgery or chemotherapy should be offered first remains
unknown. Several controversial issues are still unsettled,
and further research is required.
Acknowledgments
We thank Dr Colin K.L. Mak, MBBS, FHKAM(Path), for the
pathologic analysis.
References
1. Zighelboim J, Larson MV. Primary colonic lymphoma. Clinical
presentation, histopathologic features, and outcome with
combination chemotherapy. J Clin Gastroenterol. 1994;18:
291e297.
2. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of
extranodal lymphomas. Cancer. 1972;29:252e260.
3. Herrmann R, Panahon AM, Barcos MP, Walsh D, Stutzman L.
Gastrointestinal involvement in non-Hodgkin’s lymphoma.
Cancer. 1980;46:215e222.
4. Fan CW, Changchien CR, Wang JY, et al. Primary colorectal
lymphoma. Dis Colon Rectum. 2000;43:1277e1282.
5. Wang MH, Wong JM, Lien HC, Lin CW, Wang CY. Colonoscopic
manifestations of primary colorectal lymphoma. Endoscopy.
2001;33:605e609.
6. Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid
tumours of the intestinal tract. Report of 37 cases with a study
of factors influencing prognosis. Br J Surg. 1961;49:80e89.
7. Shepherd NA, Hall PA, Coates PJ, Levison DA. Primary malig-
nant lymphoma of the colon and rectum. A histopathological
and immunohistochemical analysis of 45 cases with clinico-
pathological correlations. Histopathology. 1988;12:235e252.
8. Ruskone-Fourmestraux A, Aegerter P, Delmer A, Brousse N,
Galian A, Rambaud JC. Primary digestive tract lymphoma:
aprospectivemulticentric studyof91patients.Grouped’Etudedes
Lymphomes Digestifs. Gastroenterology. 1993;105:1662e1671.
114 W.-H. She et al.9. Amer MH, el Akkad S. Gastrointestinal lymphoma in adults:
clinical features and management of 300 cases. Gastroenter-
ology. 1994;106:846e858.
10. Hwang WS, Yao JC, Cheng SS, Tseng HH. Primary colorectal
lymphoma in Taiwan. Cancer. 1992;70:575e580.
11. Doolabh N, Anthony T, Simmang C, et al. Primary colonic
lymphoma. J Surg Oncol. 2000;74:257e262.
12. Pandey M, Kothari KC, Wadhwa MK, Patel HP, Patel SM,
Patel DD. Primary malignant large bowel lymphoma. Am Surg.
2002;68:121e126.
13. Kim YH, Lee JH, Yang SK, et al. Primary colon lymphoma in
Korea: a KASID (Korean Association for the Study of Intestinal
Diseases) study. Dig Dis Sci. 2005;50:2243e2247.
14. Gonzalez QH, Heslin MJ, Da´vila-Cervantes A, et al. Primary
colonic lymphoma. Am Surg. 2008;74:214e216.15. Campo E, Gaulard P, Zucca E, et al. Report of the European
task force on lymphomas: workshop on peripheral T-cell
lymphomas. Ann Oncol. 1998;9:835e843.
16. Chan JK. Peripheral T-cell and NK-cell neoplasms: an
integrated approach to diagnosis. Mod Pathol. 1999;12:
177e199.
17. Meyers PA, Potter VP, Wollner N, Exelby P. Bowel perforation
during initial treatment for childhood non-Hodgkin’s
lymphoma. Cancer. 1985;56:259e261.
18. McDermott EW, Cassidy N, Heffernan SJ. Perforation through
undiagnosed small bowel involvement in primary thyroid
lymphoma during chemotherapy. Cancer. 1992;69:572e573.
19. Ara C, Coban S, Kayaalp C, Yilmaz S, Kirimlioglu V. Spontaneous
intestinal perforation due to non-Hodgkin’s lymphoma: evalu-
ation of eight cases. Dig Dis Sci. 2007;52:1752e1756.
